|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
8136510 |
| 003 |
ICU |
| 005 |
20110207171800.0 |
| 008 |
100511s2010 dcua b 000 0 eng |
| 010 |
|
|
|a 2010020157
|
| 020 |
|
|
|a 9780309151290 (pbk.)
|
| 020 |
|
|
|a 0309151295 (pbk.)
|
| 020 |
|
|
|a 9780309151306 (pdf)
|
| 020 |
|
|
|a 0309151309 (pdf)
|
| 035 |
|
|
|a 8136510
|
| 035 |
|
|
|a 2010020157
|
| 035 |
|
|
|a (OCoLC)614271791
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d YDX
|d NLM
|d NRC
|d CDX
|d UBY
|d YDXCP
|d IXA
|d UtOrBLW
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a R853.B54
|b E93 2010
|
| 060 |
1 |
0 |
|a QW 541
|b E917 2010
|
| 082 |
0 |
0 |
|a 610.28
|2 22
|
| 245 |
0 |
0 |
|a Evaluation of biomarkers and surrogate endpoints in chronic disease /
|c Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease, Board on Health Care Services, Board on Health Sciences Policy, Food and Nutrition Board, Institute of Medicine ; Christine M. Micheel and John R. Ball, editors.
|
| 260 |
|
|
|a Washington, D.C. :
|b National Academies Press,
|c c2010.
|
| 300 |
|
|
|a xx, 314 p. :
|b ill. ;
|c 23 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 505 |
0 |
|
|a Review : evaluating and regulating biomarker use -- The biomarker evaluation process -- Case studies-- Strengthening evidence-based regulation.
|
| 520 |
|
|
|a "Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process."--Publisher's description.
|
| 650 |
|
0 |
|a Biochemical markers
|x Evaluation.
|
| 650 |
|
0 |
|a Chronic diseases.
|0 http://id.loc.gov/authorities/subjects/sh85025392
|
| 650 |
1 |
2 |
|a Biological Markers.
|
| 650 |
2 |
2 |
|a Chronic Disease.
|
| 650 |
2 |
2 |
|a Evidence-Based Practice.
|
| 650 |
|
7 |
|a Biochemical markers
|x Evaluation.
|2 fast
|0 http://id.worldcat.org/fast/fst00831951
|
| 650 |
|
7 |
|a Chronic diseases.
|2 fast
|0 http://id.worldcat.org/fast/fst00860072
|
| 700 |
1 |
|
|a Micheel, Christine.
|1 http://viaf.org/viaf/272500149
|0 http://id.loc.gov/authorities/names/no2009004337
|
| 700 |
1 |
|
|a Ball, John,
|d 1944-
|1 http://viaf.org/viaf/38596342
|0 http://id.loc.gov/authorities/names/n93804400
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.).
|b Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease.
|1 http://viaf.org/viaf/136289277
|0 http://id.loc.gov/authorities/names/n2010182021
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 9eee69e4-19ef-55cb-8aac-f3210e3eebc0
|s 66d4b3db-ee33-5d6e-bcc4-e6da28cf9957
|
| 928 |
|
|
|t Library of Congress classification
|a R853.B54 E93 2010
|l JCL
|c JCL-Sci
|i 1122526
|
| 927 |
|
|
|t Library of Congress classification
|a R853.B54 E93 2010
|l JCL
|c JCL-Sci
|e KIER
|e CRERAR
|b 099583566
|i 8814417
|
